Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA staff: Medicines Co.'s Cangrelor drug should not be approved
Reuters
Monday, February 10, 2014 - 8:45am
tags:
FDA, Cangrelor, The Medicines Company
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Monday, February 10, 2014 - 8:43am
tags:
diabetes, MannKind, Merck, Novo Nordisk, NeoStem, Regeneron
High Expectations Still Haunt Intuitive Surgical
TheStreet.com
Monday, February 10, 2014 - 8:37am
tags:
Intuitive Surgical
The Hep C Race Is Heating Up: AbbVie Vs. Gilead
Seeking Alpha
Monday, February 10, 2014 - 8:35am
tags:
AbbVie, Gilead Sciences, hepatitis C, Sovaldi
FDA panel recommendation may give boost to Bayer's Aleve, WSJ says
Yahoo/Fly on the Wall
Monday, February 10, 2014 - 8:32am
tags:
advisory panels, FDA, Aleve, Bayer
US Biotech IPO fever stokes bubble fears
FT.com
Monday, February 10, 2014 - 8:31am
tags:
IPOs, biotech
China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
Seeking Alpha
Monday, February 10, 2014 - 8:30am
tags:
China, GSK, Abiomed, Sagent Pharmaceuticals
Novartis: Caring Investors And Curing Diseases
Seeking Alpha
Monday, February 10, 2014 - 8:29am
tags:
Novartis
Mast Therapeutics agrees to acquire Aires Pharmaceuticals
Yahoo/Fly on the Wall
Monday, February 10, 2014 - 8:28am
tags:
Mast Therapeutics, Aires Pharmaceuticals, M&A
Can Teva's New CEO Turn Its Fortunes Around
Seeking Alpha
Monday, February 10, 2014 - 8:27am
tags:
Teva Pharmaceuticals, Pharma CEOs, Erez Vigodman
Merck Falling Earnings Hide Hidden Potential
Motley Fool
Sunday, February 9, 2014 - 11:41am
tags:
Merck, earnings
Teva Reports Strong Q4 And 2013 Results
Pharmaceutical Online
Saturday, February 8, 2014 - 1:18pm
tags:
Teva Pharmaceuticals, earnings
Roche gets break in case against India sales of cancer drug
Money Control, India
Saturday, February 8, 2014 - 1:17pm
tags:
Roche, India, Herceptin, generics
Sanofi SA Looks Like One Of The Better Bargains In Big Pharma
Motley Fool
Saturday, February 8, 2014 - 12:52pm
tags:
Sanofi
Fundamentals Continue To Look Strong At Neurocrine Bio
Seeking Alpha
Saturday, February 8, 2014 - 12:51pm
tags:
Neurocrine Biosciences
Intercept Pharmaceuticals: How You Could Benefit From Upcoming Catalysts
Seeking Alpha
Saturday, February 8, 2014 - 12:50pm
tags:
Intercept Pharma
The Effects Of Copycat Drugs on Novartis, Merck, and Eli Lilly
Motley Fool
Saturday, February 8, 2014 - 12:49pm
tags:
Eli Lilly, Novartis, Merck, generics
Will These Two Drugs Turn Around Losses at Pfizer?
Motley Fool
Saturday, February 8, 2014 - 10:33am
tags:
Pfizer, palbociclib, breast cancer, vaccines, Prevnar vaccine, pneumonia
Pfizer Wins Exclusivity on Lyrica Until 2018
Wall St Cheat Sheet
Saturday, February 8, 2014 - 10:30am
tags:
Pfizer, Lyrica, patents
Loss at Theravance Wider Than Expected
Yahoo/Zacks
Saturday, February 8, 2014 - 10:29am
tags:
Theravance, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.